Preferred Label : Tuberous sclerosis 2;
Symbol : TSC2;
CISMeF acronym : TSC2;
Type : Phenotype, molecular basis known;
Included titles and symbols : Tsc2 angiomyolipomas, renal, modifier of;
Description : Tuberous sclerosis complex (TSC) is an autosomal dominant multisystem disorder characterized
by hamartomas in multiple organ systems, including the brain, skin, heart, kidneys,
and lung. These changes can result in epilepsy, learning difficulties, behavioral
problems, and renal failure, among other complications (reviews by Crino et al., 2006
and Curatolo et al., 2008). For a general phenotypic description and a discussion
of genetic heterogeneity of tuberous sclerosis, see tuberous sclerosis-1 (191100),
caused by mutation in the TSC1 gene (605284) on chromosome 9q34. Approximately 10
to 30% of cases of tuberous sclerosis are due to mutations in the TSC1 gene: the frequency
of cases due to mutations in the TSC2 gene is consistently higher. TSC2 mutations
are associated with more severe disease (Crino et al., 2006) (see GENOTYPE/PHENOTYPE;
Inheritance : Autosomal dominant;
Molecular basis : Caused by mutation in the tuberin gene (TSC2, 191092.0001);
Neoplasia : Myocardial rhabdomyoma; Multiple bilateral renal angiomyolipoma; Ependymoma; Renal carcinoma; Giant cell astrocytoma; Chordoma; Benign tumors of the eye, heart, and lungs;
Laboratory abnormalities : Increased frequency of premature centromere disjunction (PCD) in cultured fibroblasts,
esp. chromosome 3; Allelic loss on 16p13.3 in angiomyolipoma, cardiac rhabdomyoma, cortical tuber, and
giant cell astrocytoma;
Prefixed ID : #613254;
Origin ID : 613254;
UMLS CUI : C1860707;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)